209 related articles for article (PubMed ID: 23108401)
1. BAG-1 suppresses expression of the key regulatory cytokine transforming growth factor β (TGF-β1) in colorectal tumour cells.
Skeen VR; Collard TJ; Southern SL; Greenhough A; Hague A; Townsend PA; Paraskeva C; Williams AC
Oncogene; 2013 Sep; 32(38):4490-9. PubMed ID: 23108401
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β1 gene promoter -509C/T polymorphism in association with expression affects colorectal cancer development and depends on gender.
Stanilova S; Stanilov N; Julianov A; Manolova I; Miteva L
PLoS One; 2018; 13(8):e0201775. PubMed ID: 30071009
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
4. BAG-1 interacts with the p50-p50 homodimeric NF-κB complex: implications for colorectal carcinogenesis.
Southern SL; Collard TJ; Urban BC; Skeen VR; Smartt HJ; Hague A; Oakley F; Townsend PA; Perkins ND; Paraskeva C; Williams AC
Oncogene; 2012 May; 31(22):2761-72. PubMed ID: 21963853
[TBL] [Abstract][Full Text] [Related]
5. The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer.
Rojas A; Meherem S; Kim YH; Washington MK; Willis JE; Markowitz SD; Grady WM
Int J Cancer; 2008 Jul; 123(1):14-21. PubMed ID: 18425817
[TBL] [Abstract][Full Text] [Related]
6. EHF promotes colorectal carcinoma progression by activating TGF-β1 transcription and canonical TGF-β signaling.
Wang L; Ai M; Nie M; Zhao L; Deng G; Hu S; Han Y; Zeng W; Wang Y; Yang M; Wang S
Cancer Sci; 2020 Jul; 111(7):2310-2324. PubMed ID: 32372436
[TBL] [Abstract][Full Text] [Related]
7. BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-kappaB activity.
Clemo NK; Collard TJ; Southern SL; Edwards KD; Moorghen M; Packham G; Hague A; Paraskeva C; Williams AC
Carcinogenesis; 2008 Apr; 29(4):849-57. PubMed ID: 18204076
[TBL] [Abstract][Full Text] [Related]
8. Let-7a Inhibits Tumor Metastasis by Regulating TGF-β/Smad Signaling in the Colorectal Adenocarcinoma Cell Line LS-174T.
Cao W; Wang Q; Huang C
Anticancer Res; 2021 Aug; 41(8):3801-3808. PubMed ID: 34281839
[TBL] [Abstract][Full Text] [Related]
9. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
[No Abstract] [Full Text] [Related]
10. The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells.
Lee EO; Kang JL; Chong YH
J Biol Chem; 2005 Mar; 280(9):7845-53. PubMed ID: 15632190
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study.
Cardillo MR; Yap E
J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of cancerous progression by LISCH7 via direct stimulation of TGFB1 transcription in triple-negative breast cancer.
Tang X; Zhou Y; Liu Y; Zhang W; Liu C; Yan C
J Cell Biochem; 2020 Nov; 121(11):4642-4653. PubMed ID: 32048750
[TBL] [Abstract][Full Text] [Related]
14. Involvement of smad2 and Erk/Akt cascade in TGF-β1-induced apoptosis in human gingival epithelial cells.
Yoshimoto T; Fujita T; Kajiya M; Matsuda S; Ouhara K; Shiba H; Kurihara H
Cytokine; 2015 Sep; 75(1):165-73. PubMed ID: 25882870
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
[TBL] [Abstract][Full Text] [Related]
16. Active TGF-beta1 correlates with myofibroblasts and malignancy in the colorectal adenoma-carcinoma sequence.
Hawinkels LJ; Verspaget HW; van der Reijden JJ; van der Zon JM; Verheijen JH; Hommes DW; Lamers CB; Sier CF
Cancer Sci; 2009 Apr; 100(4):663-70. PubMed ID: 19462508
[TBL] [Abstract][Full Text] [Related]
17. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
[TBL] [Abstract][Full Text] [Related]
18. Nuclear BAG-1 expression inhibits apoptosis in colorectal adenoma-derived epithelial cells.
Barnes JD; Arhel NJ; Lee SS; Sharp A; Al-Okail M; Packham G; Hague A; Paraskeva C; Williams AC
Apoptosis; 2005 Mar; 10(2):301-11. PubMed ID: 15843891
[TBL] [Abstract][Full Text] [Related]
19. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive look at transcription factor gene expression changes in colorectal adenomas.
Vonlanthen J; Okoniewski MJ; Menigatti M; Cattaneo E; Pellegrini-Ochsner D; Haider R; Jiricny J; Staiano T; Buffoli F; Marra G
BMC Cancer; 2014 Jan; 14():46. PubMed ID: 24472434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
